ROIVANT SCIENCES LTD. Public Float
ROIVANT SCIENCES LTD. (ROIV) had Public Float of $9.80 billion as of 2025-09-30, per its 10-K filed 2026-05-20.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-05-20
- 2025-09-30: Entity Public Float $9.80B.
- 2024-09-30: Entity Public Float $8.10B.
- 2023-09-29: Entity Public Float $8.00B.
- 2022-09-30: Entity Public Float $445.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-09-30 | $9.80B 10-K · filed 2026-05-20 |
| 2024-09-30 | $8.10B 10-K · filed 2025-05-29 |
| 2023-09-29 | $8.00B 10-K · filed 2024-05-30 |
| 2022-09-30 | $445.20M 10-K · filed 2023-06-28 |
| 2021-10-01 | $1.12B 10-K · filed 2022-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |